NEULAND LABORATORIES
Back to All Ratios
|
NEULAND LABORATORIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 253.82 | 280.42 | 168.59 | 87.97 | 93.78 |
What is the latest Cash Earnings per Share (CEPS) ratio of NEULAND LABORATORIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 253.82 |
| Mar2024 | 280.42 |
| Mar2023 | 168.59 |
| Mar2022 | 87.97 |
| Mar2021 | 93.78 |
How is Cash Earnings per Share (CEPS) of NEULAND LABORATORIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 253.82 | -9.49 | |
| Mar2024 | 280.42 | 66.33 | |
| Mar2023 | 168.59 | 91.64 | |
| Mar2022 | 87.97 | -6.20 | |
| Mar2021 | 93.78 | - | |
Other Financial Ratios of NEULAND LABORATORIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹14,783.7 Cr | -5.9% | -11.4% | 6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,889.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,133.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,492.9 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -5.9% |
-11.4% |
6.1% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses